NextStep Arthropedix, LLC
$125.7K 36 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Clariance, Inc.
Clariance, Inc. reported $125,494.54 across General Payments, Research, and Ownership to 206 physicians and teaching hospitals across 206 transactions.
- $125.5K
- All-tracks total
- 206
- Transactions
- 206
- Recipients
- +$19.3K
- General Payments vs PY2023
Clariance, Inc. reported $125,494.54 across all CMS Open Payments tracks (General + Research + Ownership) to 206 physicians and teaching hospitals in Program Year 2024 - ranking #1121 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $125,494.54, averaging $609.20 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer clariance-inc Clariance, Inc.
$125.5K · #1121/1,925 · 0.0% industry · PY2024
- TOT $125.5K
- RANK #1121
- SHARE 0.0%
- TXN 206
- RCP 206
- CAT 5
- GEN $125.5K
- ΔGEN +$19.3K
- TOP1 16.1%
- PY 2024
Volume peers
Nearest volume peer: NextStep Arthropedix, LLC ($125.7K)
Clariance, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Clariance, Inc.'s CMS-reported General Payments increased by $19.3K (+18.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CLARIANCE, INC.PY2023: CLARIANCE, INC.PY2024: Clariance, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $106,222.77
- PY2024
- $125,494.54
What the Data Shows for Clariance, Inc.
In Program Year 2024, Clariance, Inc. reported $125,494.54 in payments to 206 physicians and teaching hospitals across 206 individual transactions, an average of $609.20 per transaction and $609.20 per recipient. That total places Clariance, Inc. at rank #1121 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Consulting Fee" leads the 5-category general-payment breakdown below at $44.6K (35.5% of General Payments, 17 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Clariance, Inc. made 5 types of general payments. "Consulting Fee" is the largest category at $44.6K, 35.5% of General Payments.
Clariance, Inc. reports 5 general-payment categories - the top three are Consulting Fee (35.5%), Travel and Lodging (34.0%), and Grant (15.9%). The remaining 2 categories make up 14.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Clariance, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $44.6K | 17 | 35.5% |
| Travel and Lodging | $42.6K | 58 | 34.0% |
| Grant | $20.0K | 1 | 15.9% |
| Food and Beverage | $11.8K | 125 | 9.4% |
| Honoraria | $6.5K | 5 | 5.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $71,760.62 (57.2%) of $125,494.54 in this company's General Payments records across 45 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Clariance, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
RICHARD Burton MEYRAT
$20,247.89 across 6 reported transactions
- 2
Lane Spero
$14,178.41 across 22 reported transactions
- 3
Mukund Gundanna
$12,996.86 across 16 reported transactions
- 4
BLAKE Wade BERMAN
$12,667.30 across 10 reported transactions
- 5
Justin Dazley
$11,670.16 across 11 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Clariance, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Clariance, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Clariance, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Profound Medical Corp.
$125.2K 133 recipients
Compare payment profiles
FEMSelect Inc.
$126.2K 193 recipients
Compare payment profiles
Reflow Medical Inc
$126.3K 1,044 recipients
Compare payment profiles
Biotest AG
$124.5K 5 recipients
Compare payment profiles
World Class Technology Corporation
$124.1K 1,299 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.